These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30157293)

  • 1. Separation and determination of alpha-synuclein monomeric and oligomeric species using two electrophoretic approaches.
    Napp A; Houbart V; Demelenne A; Merville MP; Crommen J; Dumoulin M; Garraux G; Servais AC; Fillet M
    Electrophoresis; 2018 Dec; 39(23):3022-3031. PubMed ID: 30157293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue.
    Erdmann L; Santos PI; Rieper P; Klafki HW; Beutner D; Wiltfang J; Outeiro TF; Setz C
    J Parkinsons Dis; 2024; 14(4):681-692. PubMed ID: 38578903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disentangling aggregation-prone proteins: a new method for isolating α-synuclein species: An Editorial Highlight for "A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research" on page 103.
    Nichols MR
    J Neurochem; 2020 Apr; 153(1):7-9. PubMed ID: 32037541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
    Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
    Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
    Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.
    Polinski NK; Volpicelli-Daley LA; Sortwell CE; Luk KC; Cremades N; Gottler LM; Froula J; Duffy MF; Lee VMY; Martinez TN; Dave KD
    J Parkinsons Dis; 2018; 8(2):303-322. PubMed ID: 29400668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification.
    Fenyi A; Leclair-Visonneau L; Clairembault T; Coron E; Neunlist M; Melki R; Derkinderen P; Bousset L
    Neurobiol Dis; 2019 Sep; 129():38-43. PubMed ID: 31078683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease.
    Gonçalves SA; Outeiro TF
    Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein-Confocal Nanoscanning (ASYN-CONA), a Bead-Based Assay for Detecting Early-Stage α-Synuclein Aggregation.
    Pérez-Pi I; Evans DA; Horrocks MH; Pham NT; Dolt KS; Koszela J; Kunath T; Auer M
    Anal Chem; 2019 May; 91(9):5582-5590. PubMed ID: 30964656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.
    Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF
    PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.
    Lima VA; Esquinelato R; Carmo-Gonçalves P; Nascimento LAD; Lee H; Eliezer D; Romão L; Follmer C
    FEBS Lett; 2022 Feb; 596(3):309-322. PubMed ID: 34928512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease.
    Papadopoulos VE; Nikolopoulou G; Antoniadou I; Karachaliou A; Arianoglou G; Emmanouilidou E; Sardi SP; Stefanis L; Vekrellis K
    Hum Mol Genet; 2018 May; 27(10):1696-1710. PubMed ID: 29547959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis.
    Ouzounoglou E; Kalamatianos D; Emmanouilidou E; Xilouri M; Stefanis L; Vekrellis K; Manolakos ES
    BMC Syst Biol; 2014 May; 8():54. PubMed ID: 24885905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis.
    Moussa CE; Wersinger C; Rusnak M; Tomita Y; Sidhu A
    Neurosci Lett; 2004 Nov; 371(2-3):239-43. PubMed ID: 15519765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic Metamorphosis-How Changes from Lysosomal to Cytosolic pH Modify the Alpha-Synuclein Aggregation Pattern.
    Eymsh B; Drobny A; Heyn TR; Xiang W; Lucius R; Schwarz K; Keppler JK; Zunke F; Arnold P
    Biomacromolecules; 2020 Dec; 21(12):4673-4684. PubMed ID: 32986422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC.
    Ruf VC; Shi S; Schmidt F; Weckbecker D; Nübling GS; Ködel U; Mollenhauer B; Giese A
    FEBS Open Bio; 2020 May; 10(5):883-893. PubMed ID: 32190992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
    Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J
    Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
    Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
    Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
    Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
    Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.